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OPEN
ORIGINAL ARTICLE
Longitudinal exome-wide association study to identify
genetic susceptibility loci for hypertension in a
Japanese population
Yoshiki Yasukochi1,2, Jun Sakuma2,3,4, Ichiro Takeuchi2,4,5, Kimihiko Kato1,6, Mitsutoshi Oguri1,7,
Tetsuo Fujimaki8, Hideki Horibe9 and Yoshiji Yamada1,2
Genome-wide association studies have identiﬁed various genetic variants associated with complex disorders. However, these
studies have commonly been conducted in a cross-sectional manner. Therefore, we performed a longitudinal exome-wide
association study (EWAS) in a Japanese cohort. We aimed to identify genetic variants that confer susceptibility to hypertension
using ~244 000 single-nucleotide variants (SNVs) and physiological data from 6026 Japanese individuals who underwent
annual health check-ups for several years. After quality control, the association of hypertension with SNVs was tested using a
generalized estimating equation model. Finally, our longitudinal EWAS detected seven hypertension-related SNVs that passed
strict criteria. Among these variants, six SNVs were densely located at 12q24.1, and an East Asian-speciﬁc motif (haplotype)
‘CAAAA’ comprising ﬁve derived alleles was identiﬁed. Statistical analyses showed that the prevalence of hypertension in
individuals with the East Asian-speciﬁc haplotype was signiﬁcantly lower than that in individuals with the common haplotype
‘TGGGT’. Furthermore, individuals with the East Asian haplotype may be less susceptible to the adverse effects of smoking on
hypertension. The longitudinal EWAS for the recessive model showed that a novel SNV, rs11917356 of COL6A5, was
signiﬁcantly associated with systolic blood pressure, and the derived allele at the SNV may have spread throughout East Asia in
recent evolutionary time.
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INTRODUCTION
Hypertension is a major complex disorder affected by both
genetic background and environmental factors, including life-
style. In 2014, the Ministry of Health, Labour and Welfare
reported that the estimated number of Japanese patients
receiving medical treatment for hypertension had increased
by ~ 10% since 2011 and was more than 10 million1 (http://
www.mhlw.go.jp/english/database/db-hss/). Therefore, the
exploration of genetic variants that confer susceptibility to
hypertension is important for the personalized prevention of
hypertension.
In recent decades, genome-wide association studies
(GWASs) in various ethnic populations have identiﬁed genes,
or loci, associated with hypertension.2–7 Two GWASs for
systolic (SBP) and diastolic blood pressures (DBP) in
~ 30 000 individuals of European ancestry identiﬁed 13
hypertension-associated loci.2,3 Subsequently, a large-scale
GWAS using a multistage design to examine DBP and SBP
in 200 000 individuals of European ancestry detected an
additional 16 novel single-nucleotide variants (SNVs).4 How-
ever, the latter GWAS detected fewer than 10 SNVs associated
with DBP or SBP in non-European populations. This dis-
crepancy could reﬂect the small sample size or differences in
genetic backgrounds among populations, or this ﬁnding could
be a true and valid result.
For the most part, conventional GWASs have been con-
ducted in a cross-sectional manner that commonly measures
traits at a single point in time. SBP, DBP and the prevalence of
hypertension are signiﬁcantly correlated with age. Therefore,
control individuals who have normal blood pressure at a
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certain point will potentially display hypertension after a few
years. Conventional cross-sectional GWASs do not consider
this possibility. Given that longitudinal GWASs evaluate
temporal changes in blood pressure and the prevalence of
hypertension related to age, this analysis increases the statistical
power to detect these associations. Therefore, we traced disease
progression and physiological changes in 6026 Japanese indi-
viduals who underwent annual health check-ups for several
years. We performed a longitudinal exome-wide association
study (EWAS), which is suited to studying the effects of low
frequency or rare variants within a gene of interest, to explore
novel genetic variants that confer susceptibility to hypertension,
focusing on rare coding variants, such as East Asian-speciﬁc
alleles. The results of this longitudinal EWAS enhance the
current understanding of the relationship between ethnic-
speciﬁc genetic factors and diseases.
MATERIALS AND METHODS
Ethics statement
The study protocol complied with the Declaration of Helsinki and was
approved through the Committees on the Ethics of Human Research
of Mie University Graduate School of Medicine and Inabe General
Hospital. Written informed consent was obtained from all subjects
before enrolment in the present study.
Study population
The 6026 community-dwelling individuals in Inabe City, Mie Pre-
fecture, Japan, were recruited from individuals who visited the health-
care center of Inabe General Hospital for an annual health check-up
and were followed-up yearly (Inabe cohort). We refer to this cohort as
the ‘Inabe cohort’. Individuals in the Inabe cohort were registered
between March 2010 and September 2012, and genomic DNA was
extracted from venous blood cells using a DNA extraction kit
(SMITEST EX-R&D; Medical and Biological Laboratories, Nagoya,
Japan) and stored in the genomic DNA bank of the Research Center
for Genomic Medicine at Mie University. For all participants, medical
examination data obtained from April 2003 to March 2014 (11 years)
were deposited into a database. Each subject had one set of health data
for each year of attendance at the clinic. Therefore, all participants had
undergone 1–11 medical examinations (a total of 28 529 examina-
tions), and the average follow-up period was 5 years. The detailed
characteristics of the study subjects in a 5-year follow-up are described
elsewhere.8
Among the 6026 subjects in the Inabe cohort, 2249 patients were
affected by essential hypertension, and the remaining 3777 patients
were treated as controls. Hypertension was deﬁned as either DBP of
⩾ 90 mmHg or SBP of ⩾ 140 mmHg (or both), by virtue of the
subject having taken antihypertensive medication. Blood pressure was
measured at least twice with the subjects having rested in the sitting
position for 45 min. A skilled physician or nurse obtained the
measurements according to the guidelines of the American Heart
Association.9 The mean DBP of all subjects was 74.7 mmHg, whereas
the mean SBP was 120.7 mmHg. The mean age of subjects was 52.5
years of age (18–91 years of age) and the mean body mass index was
23.0 kg m− 2. The percentages of missing data were 2.2% for DBP, SBP
and body mass index. There were no missing data for age, gender or
smoking status.
Longitudinal EWAS
A longitudinal EWAS for hypertension was performed on the Inabe
cohort, and Inﬁnium HumanExome-12 ver. 1.2 BeadChip or Inﬁnium
Exome-24 ver. 1.0 BeadChip (Illumina, San Diego, CA, USA) were
used to genotype ~ 244 000 SNVs. The exome array includes putative
functional exonic variants selected from 412 000 ethnically diverse
individuals.10 Previously available marker sets of GWASs were
designed to identify common alleles (minor allele frequency (MAF)
of ⩾ 5%) and were not well suited to studying the effects of low
frequency or rare variants within a gene of interest. The exome arrays
used in the present study contained ~ 244 000 SNVs, including
common, low-frequency (0.5%⩽MAFo5%) and rare (MAFo0.5%)
variants, although EWAS is a focused genotyping method that differs
from GWAS, which includes up to 4.5 million markers for SNVs
and copy number variations. Using JMP Genomics version 6.0
(SAS Institute, Cary, NC, USA), the genotyping data of 6026
individuals were converted into binary data with the dominant and
recessive models, after removing monomorphic sites among subjects,
resulting in 58 563 SNVs for the dominant model and 38 725 SNVs
for the recessive model. In a similar manner, the genotyping data were
also converted into numerical data with the additive model, generating
58 563 SNVs. The dominant and recessive models were deﬁned as
‘AA (0) vs AB+BB (1)’ and ‘AA+AB (0) vs BB (1)’ (A, major allele;
B, minor allele), respectively, whereas the additive model was deﬁned
as ‘AA (0)oAB (1)oBB (2)’. SNVs on the mitochondrial genome and
sex chromosomes were removed from these analyses; SNVs in which
the genotype distribution signiﬁcantly deviated from Hardy–Weinberg
equilibrium (Po0.001) in controls were also discarded.
Sitlani et al.11 reported that a small effective sample size can increase
the chances of generating false positives (type I errors). In the
preliminary analysis, a MAF of o0.01 appeared to increase type I
errors in the recessive model because extraordinarily large numbers of
SNVs were identiﬁed as hypertension-associated SNVs. Therefore, we
discarded SNVs with a MAF of o0.05. Quantile–quantile plots for
P-values of allele frequencies in the EWASs for DBP, SBP, or the
prevalence of hypertension in all genetic models are shown in
Supplementary Figure S1. The genomic inﬂation factor (λ) of P-values
was 1.10 for the prevalence of hypertension and 1.09 for DBP and SBP
in the dominant model (Supplementary Figure S1a). In the additive
model, the λ was 1.12 for the prevalence of hypertension and 1.09 for
DBP and SBP (Supplementary Figure S1b). In the recessive model, the
λ was 1.07 for the prevalence of hypertension, 1.09 for DBP and 1.14
for SBP (Supplementary Figure S1c).
The genotype data of participants in the EWAS were examined for
population stratiﬁcation using principal component analysis according
to the EIGENSTRAT method12 with the JMP Genomics program
(Supplementary Figure S2), and we excluded four outliers identiﬁed in
the analysis. The rearrangement of Inabe longitudinal data was
conducted using R software version 3.3213 via RStudio version
1.0.13614 and Perl script.
Statistical analyses
The association of longitudinal changes in the prevalence of hyperten-
sion, DBP and SBP with genetic variants was examined using the
generalized estimating equation (GEE) model15,16 with adjustments
for age, gender, body mass index and smoking status, using the R
package ‘geepack’.17 The waves argument was used to specify the
ordering of repeated measurements within individuals. The statistical
signiﬁcance of the association was Po8.54× 10− 7 (0.05/58 563 SNVs)
for dominant and additive models and Po1.29× 10− 6 (0.05/38 725
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SNVs) for the recessive model after applying Bonferroni’s correction
to compensate for the multiple comparison of genotypes with the
clinical parameters. Sitlani and colleagues proposed that compared
with the use of normal distribution, the use of a t reference
distribution with estimated degrees of freedom for the distributional
assumption of the ratio of coefﬁcient estimate to its standard error can
improve the accuracy of the signiﬁcance detected with the GEE. In
addition, these authors recommended the use of approxdf, a scale of
small effective sample size:11 approxdf= 2×MAF×Nindep, where
Nindep is the sum of the estimated number of independent observa-
tions per person. We also computed the P-value via GEE using a t
reference distribution with Satterthwaite estimates of degrees of
freedom and approxdf using the R package ‘bosswithdf’,11,18 and
discarded SNVs with approxdf o10, as approxdf ⩾ 10 decreases the
chances of generating type I errors.11 The GEE with t reference
distribution was implemented using the clinical parameters of subjects
in the last 5 years for which data were available.
The signiﬁcance of difference of DBP or SBP between groups of
subjects with different genotypes was assessed using Welch’s t-test
(two-sided P-value o0.05). Haplotype phase and linkage disequili-
brium (LD) among SNVs were estimated using IMPUTE2 version 2.3.
219 and Haploview version 4.220 programs, respectively. Perl and R
scripts were written to convert the SNV data used in the present study
into suitable formats for each program.
Survey of allele frequencies in human populations and
variants in nonhuman primates
Information on allele frequencies of target SNVs within human
populations was obtained from the 1000 Genomes Project21 (http://
www.internationalgenome.org/) and the Integrative Japanese Genome
Variation Database (iJGVD) from the Tohoku Medical Megabank
Organization of Tohoku University22 (https://ijgvd.megabank.tohoku.
ac.jp/author/tommo/). In addition, a genetic variant at the homo-
logous SNVs within vertebrates was investigated in the UCSC Genome
Browser (for archaic humans) or Multiz Alignments of 100 Verte-
brates in the UCSC database (http://genome.ucsc.edu), and informa-
tion on allele frequencies in great apes was obtained from the Great
Ape Genome Project database23 (http://biologiaevolutiva.org/greatape/).
RESULTS
Association of SNVs with hypertension in the Inabe cohort
In the present study, the GEE model with adjustments for age,
gender, body mass index and smoking status was used to
examine the association between 58 563 SNVs for the domi-
nant and additive models, and 38 725 SNVs for the recessive
model and clinical parameters related to hypertension in the
Inabe cohort (after removing four outliers identiﬁed using the
principal component analysis; Supplementary Figure S2). In
the dominant and additive models, six SNVs located at
12q24.11–12q24.13 were signiﬁcantly (Po8.54× 10− 7) asso-
ciated with all three clinical parameters: the prevalence of
hypertension; SBP; and DBP (Figure 1; Table 1). In addition,
three SNVs located on chromosome 10 were signiﬁcantly
associated with SBP in the dominant and additive models,
and one additional SNV located on the same chromosomal
region showed a signiﬁcant association with SBP in the additive
model (Figure 1; Table 1). In the recessive model, four SNVs
were signiﬁcantly (Po1.29× 10− 6) associated with the pre-
valence of hypertension, and one and ﬁve SNVs were sig-
niﬁcantly associated with SBP and DBP, respectively (Figure 1;
Table 1).
To conﬁrm the associations between candidate SNVs
detected in the longitudinal EWAS and clinical parameters
related to hypertension, we applied the GEE model with t refer-
ence distribution and threshold of approxdf (⩾10). Additional
analysis showed that all six SNVs at 12q24.11–12q24.13
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rs671 [G/A (E504K)a, ALDH2 gene]
rs2074356 (G/A, HECTD4 gene)
rs11066280 (T/A, HECTD4 gene)
rs11917356 [G/A (D504G)a, COL6A5 gene]
Figure 1 Single-nucleotide variants (SNVs) showing signiﬁcant associations with hypertension. The associations were examined using the
generalized estimating equation (GEE) model in the dominant (a), additive (b) and recessive (c) genetic models. The seven candidates of
hypertension-associated SNVs shown in the ﬁgure were determined when the association was supported by the GEE model with normal
and t reference distributions, and the approxdf value of these SNVs was higher than 30 (see text). The three GEE analyses independently
tested the association between SNVs and three clinical parameters: prevalence of hypertension (HT); systolic blood pressure (SBP); and
diastolic blood pressure (DBP). On the basis of Bonferroni’s correction, P-values of o8.54×10−7 for the dominant and additive models
and Po1.29×10−6 for the recessive model were considered statistically signiﬁcant. aAmino-acid change reﬂecting a point mutation at
each SNV (nonsynonymous substitution).
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Table 1 Candidate SNVs showing signiﬁcant associations with clinical parameters associated with hypertension using the
generalized estimating equation model with adjustments for age, gender, BMI and smoking status
Modela Trait/disease Ref SNP ID Allele Positionb Gene Genotypea Estimatec
P-value
(n ref. dist)d MAF Approxdfe
P-value
(t ref. dist)f
Dominant HT rs12229654 T→G 12: 111 414 461 TT vs TG+GG −0.35 2.4×10−8 0.253 256.4 1.3×10−5
rs3782886 T→C 12: 112 110 489 BRAP TT vs TC+CC −0.39 9.8×10−11 0.318 338.6 6.6×10−9
rs11066015 G→A 12: 112 168 009 ACAD10 GG vs GA+AA −0.41 1.9×10−11 0.300 336.5 2.7×10−9
rs671 G→A 12: 112 241 766 ALDH2 GG vs GA+AA −0.41 3.0×10−11 0.301 337.4 3.9×10−9
rs2074356 G→A 12: 112 645 401 HECTD4 GG vs GA+AA −0.37 1.9×10−9 0.278 304.3 1.7×10−7
rs11066280 T→A 12: 112 817 783 HECTD4 TT vs TA+AA −0.37 1.7×10−9 0.313 338.1 4.1×10−8
SBP rs12413409 G→A 10: 104 719 096 CNNM2 GG vs GA+AA −1.62 8.1×10−7 0.273 253.9 0.014
rs11191548 T→C 10: 104 846 178 TT vs TC+CC −1.62 7.7×10−7 0.273 252.4 0.014
rs11191580 T→C 10: 104 906 211 NT5C2 TT vs TC+CC −1.63 7.4×10−7 0.273 250.7 0.016
rs12229654 T→G 12: 111 414 461 TT vs TG+GG −1.89 1.1×10−8 0.253 224.6 3.8×10−5
rs3782886 T→C 12: 112 110 489 BRAP TT vs TC+CC −1.84 2.1×10−8 0.318 297.3 3.3×10−6
rs11066015 G→A 12: 112 168 009 ACAD10 GG vs GA+AA −2.03 5.6×10−10 0.300 295.4 1.2×10−7
rs671 G→A 12: 112 241 766 ALDH2 GG vs GA+AA −1.99 1.1×10−9 0.301 296.3 2.3×10−7
rs2074356 G→A 12: 112 645 401 HECTD4 GG vs GA+AA −1.91 5.5×10−9 0.278 266.7 2.2×10−6
rs11066280 T→A 12: 112 817 783 HECTD4 TT vs TA+AA −1.73 1.3×10−7 0.313 296.8 1.5×10−5
DBP rs12229654 T→G 12: 111 414 461 TT vs TG+GG −1.60 2.8×10−10 0.253 256.4 1.4×10−6
rs3782886 T→C 12: 112 110 489 BRAP TT vs TC+CC −1.60 3.6×10−10 0.318 338.6 1.9×10−7
rs11066015 G→A 12: 112 168 009 ACAD10 GG vs GA+AA −1.73 8.4×10−12 0.300 336.5 9.8×10−9
rs671 G→A 12: 112 241 766 ALDH2 GG vs GA+AA −1.72 1.3×10−11 0.301 337.4 1.5×10−8
rs2074356 G→A 12: 112 645 401 HECTD4 GG vs GA+AA −1.59 3.5×10−10 0.278 304.3 5.8×10−7
rs11066280 T→A 12: 112 817 783 HECTD4 TT vs TA+AA −1.54 1.3×10−9 0.313 338.1 5.0×10−7
Additive HT rs12229654 T→G 12: 111 414 461 TToTGoGG −0.30 7.7×10−9 0.270 35.3 2.4×10−5
rs3782886 T→C 12: 112 110 489 BRAP TToTCoCC −0.31 6.6×10−11 0.337 73.3 3.6×10−9
rs11066015 G→A 12: 112 168 009 ACAD10 GGoGAoAA −0.33 2.4×10−11 0.320 61.1 2.1×10−9
rs671 G→A 12: 112 241 766 ALDH2 GGoGAoAA −0.32 4.0×10−11 0.320 61.2 2.6×10−9
rs2074356 G→A 12: 112 645 401 HECTD4 GGoGAoAA −0.31 1.5×10−11 0.295 50.7 3.4×10−8
rs11066280 T→A 12: 112 817 783 HECTD4 TToTAoAA −0.30 4.7×10−10 0.332 71.8 1.2×10−8
SBP rs11191454 A→G 10: 104 660 004 AS3MT AAoAGoGG −1.29 7.2×10−7 0.290 45.1 0.029
rs12413409 G→A 10: 104 719 096 CNNM2 GGoGAoAA −1.35 2.0×10−7 0.285 43.7 0.017
rs11191548 T→C 10: 104 846 178 TToTCoCC −1.34 2.3×10−7 0.285 43.7 0.019
rs11191580 T→C 10: 104 906 211 NT5C2 TToTCoCC −1.34 2.4×10−7 0.284 44.2 0.020
rs12229654 T→G 12: 111 414 461 TToTGoGG −1.62 8.4×10−10 0.270 30.3 2.0×10−5
rs3782886 T→C 12: 112 110 489 BRAP TToTCoCC −1.55 5.5×10−10 0.337 64.0 2.2×10−8
rs11066015 G→A 12: 112 168 009 ACAD10 GGoGAoAA −1.69 3.5×10−11 0.320 53.2 1.8×10−9
rs671 G→A 12: 112 241 766 ALDH2 GGoGAoAA −1.67 4.9×10−11 0.320 53.2 2.5×10−9
rs2074356 G→A 12: 112 645 401 HECTD4 GGoGAoAA −1.68 1.3×10−10 0.295 44.3 2.0×10−8
rs11066280 T→A 12: 112 817 783 HECTD4 TToTAoAA −1.50 2.1×10−9 0.332 62.8 4.9×10−8
DBP rs12229654 T→G 12: 111 414 461 TToTGoGG −1.33 3.9×10−11 0.270 30.3 4.2×10−6
rs3782886 T→C 12: 112 110 489 BRAP TToTCoCC −1.36 1.6×10−12 0.337 64.0 1.8×10−9
rs11066015 G→A 12: 112 168 009 ACAD10 GGoGAoAA −1.45 1.4×10−13 0.320 53.2 4.3×10−10
rs671 G→A 12: 112 241 766 ALDH2 GGoGAoAA −1.45 1.2×10−13 0.320 53.3 3.6×10−10
rs2074356 G→A 12: 112 645 401 HECTD4 GGoGAoAA −1.39 2.8×10−12 0.295 44.3 9.6×10−9
rs11066280 T→A 12: 112 817 783 HECTD4 TToTAoAA −1.32 6.9×10−12 0.332 62.9 3.1×10−9
Recessive HT rs3766871 G→A 1: 237 778 084 RYR2 GG+GA vs AA −37.54 o2.0×10−16 0.051 0.3 4.4×10−4
rs11258194 T→A 10: 13 152 400 OPTN TT+TA vs AA −39.49 o2.0×10−16 0.075 0.2 2.7×10−4
rs10519996 G→C 15: 35 665 765 DPH6 GG+GC vs CC −38.52 o2.0×10−16 0.065 0.1 7.4×10−4
rs5763919 G→A 22: 30 662 763 OSM GG+GA vs AA −38.14 o2.0×10−16 0.055 0.2 4.0×10−7
SBP rs11917356 G→A 3: 130 110 550 COL6A5 GG+GA vs AA −2.93 2.3×10−8 0.320 60.3 6.4×10−5
DBP rs79450009 C→T 4: 25 673 284 SLC34A2 CC+CT vs TT −12.79 2.1×10−9 0.050 0.4 NA
rs3782886 T→C 12: 112 110 489 BRAP TT+TC vs CC −2.11 3.7×10−7 0.318 64.0 5.6×10−6
rs671 G→A 12: 112 241 766 ALDH2 GG+GA vs AA −2.16 6.7×10−7 0.301 53.3 1.4×10−5
rs2074356 G→A 12: 112 645 401 HECTD4 GG+GA vs AA −2.26 1.1×10−6 0.278 44.3 1.9×10−5
rs11066280 T→A 12: 112 817 783 HECTD4 TT+TA vs AA −2.07 6.9×10−7 0.313 62.9 3.7×10−6
Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; HT, prevalence of hypertension; MAF, minor allele frequency; NA, not available; ref. dist, reference
distribution; SBP, systolic blood pressure; SNP, single-nucleotide polymorphism; SNV, single-nucleotide variant.
aGenetic model, dominant model: AA vs AB+BB (A, major allele; B, minor allele); additive model (AAoABoBB); recessive model (AA+AB vs BB).
bPosition in NCBI build GRCh37.
cEstimate of coefﬁcient.
dP-values via generalized estimating equation (GEE) model using a normal reference distribution (a statistically signiﬁcant P-value corrected using Bonferroni’s method is
shown in bold).
eA scale of small effective sample size: approxdf=2×MAF×Nindep, where Nindep is the sum of the estimated number of independent observations per person
(approxdf of ⩾10 is shown in bold).
fP-values via the GEE model using a t reference distribution with Satterthwaite estimates of degrees of freedom (a statistically signiﬁcant P-value corrected using
Bonferroni’s method is shown in bold).
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(rs12229654 at 12q24.11, rs3782886 of BRAP, rs11066015 of
ACAD10, rs671 of ALDH2, and rs2074356 and rs11066280 of
HECTD4) detected in the dominant and additive models and
one SNV (rs11917356 of COL6A5) in the recessive model
showed signiﬁcant associations (Po0.05/the number of candi-
date SNVs in each genetic model) and values of approxdf were
430 (Table 1). Consequently, we identiﬁed the seven SNVs as
genetic variants that confer susceptibility to hypertension
(Table 2).
Identiﬁcation of East Asian-speciﬁc haplotype on
chromosome 12
Our longitudinal EWAS for hypertension in the dominant and
additive models revealed six signiﬁcant SNVs. On the basis of
the information obtained from the 1000 Genomes Project21
and iJGVD databases, we examined allele frequencies among
human populations (Table 3). Interestingly, minor (derived)
alleles of all six SNVs were speciﬁcally detected in East Asia.
This result suggests that the derived alleles were recently
expanded throughout East Asia. On the basis of clinical
parameters of subjects in the latest year for which data were
available, the prevalence of hypertension in subjects with the
East Asian-speciﬁc allele was lower than that of those with
common (ancestral) alleles at each SNV site (mean odds
ratio= 0.78, Po1.0× 10− 8 using Fisher’s exact test). Among
local Japanese populations, the frequencies of the East Asian
alleles were highest in the Inabe cohort (Table 3).
The six hypertension-associated SNVs were located at
12q24.1. Therefore, using the SNV data obtained in the present
study, we estimated the LD among these SNVs based on 232
biallelic sites spanning an ~ 2.0Mb genomic region on
chromosome 12 (Supplementary Figure S3). The LD among
the six SNVs was relatively strong for the physical distance.
Particularly, ﬁve SNVs at 12q24.12–12q24.13 (excluding
rs12229654 at 12q24.11) showed strong LDs (r240.8). There-
fore, we used these ﬁve SNVs for a haplotype estimate.
Using the IMPUTE2 program, we generated phased haplo-
types comprising 232 biallelic sites, and examined the genotype
containing the ﬁve hypertension-related SNV motifs (from left,
rs3782886 of BRAP, rs11066015 of ACAD10, rs671 of ALDH2,
and rs2074356 and rs11066280 of HECTD4) for all subjects.
In the Inabe cohort, the proportion of diplotype ‘TGGGT/
TGGGT’ was the highest (2274 subjects, 46.1%), followed by
‘TGGGT/CAAAA’ (2109 subjects, 35.0%) and ‘TGGGT/
CAAAA’ (460 subjects, 7.6%; Supplementary Table S1).
The ‘TGGGT’ haplotype comprises all ancestral alleles at each
Table 2 Seven candidate SNVs showing signiﬁcant associations with the clinical parameters associated with hypertension
Trait/disease Ref SNP ID Positiona
Gene or
locus Mutation Genotype All subjectsb Hypertensionb Controlsb
HT–SBP–DBP rs12229654 Chr12: 111 414 461 12q24.11 Silent TT 15 908 (55.8%) 5829 (60.5%) 10 079 (53.3%)
(T→G) TG 10 796 (37.8%) 3323 (34.5%) 7473 (39.6%)
GG 1823 (6.4%) 482 (5.0%) 1341 (7.1%)
HT–SBP–DBP rs3782886 Chr12: 112 110 489 BRAP Synonymous
(Arg241Arg)
TT 13 297 (46.6%) 5035 (52.3%) 8262 (43.7%)
(T→C) TC 12 380 (43.4%) 3826 (39.7%) 8554 (45.3%)
CC 2852 (10.0%) 773 (8.0%) 2079 (11.0%)
HT–SBP–DBP rs11066015 Chr12: 112 168 009 ACAD10 Silent in intron GG 13 950 (46.6%) 5258 (54.6%) 8692 (46.0%)
(G→A) GA 12 026 (43.4%) 3691 (38.3%) 8335 (44.1%)
AA 2553 (10.0%) 685 (7.1%) 1868 (9.9%)
HT–SBP–DBP rs671 Chr12: 112 241 766 ALDH2 Missense
(Glu303Lys)
GG 13 939 (48.9%) 5250 (54.5%) 8689 (46.0%)
(G→A) GA 12 026 (42.2%) 3697 (38.4%) 8329 (44.1%)
AA 2564 (8.9%) 687 (7.1%) 1877 (9.9%)
HT–SBP–DBP rs2074356 Chr12: 112 645 401 HECTD4 Silent in intron GG 14 876 (48.9%) 5498 (57.1%) 9378 (49.6%)
(G→A) GA 11 388 (42.2%) 3546 (36.8%) 7842 (41.5%)
AA 2265 (9.0%) 590 (6.1%) 1675 (8.9%)
HT–SBP–DBP rs11066280 Chr12: 112 817 783 HECTD4 Silent in intron TT 13 409 (52.1%) 5066 (52.6%) 8343 (44.2%)
(T→A) TA 12 338 (39.9%) 3816 (39.6%) 8522 (45.1%)
AA 2782 (7.9%) 752 (7.8%) 2030 (10.7%)
SBP rs11917356 Chr3: 130 110 550 COL6A5 Missense
(Asp982Gly)
GG 2917 (48.4%) 1787 (47.4%) 1130 (50.2%)
(G→A) GA 2494 (41.4%) 1556 (41.2%) 938 (41.7%)
AA 611 (10.1%) 430 (11.4%) 181 (8.0%)
Abbreviations: DBP, diastolic blood pressure; HT, prevalence of hypertension; SBP, systolic blood pressure; SNP, single-nucleotide polymorphism; SNV, single-nucleotide
variant.
aPosition in NCBI build GRCh37.
bValues indicate the numbers of measurements obtained, and the percentages are indicated in parentheses.
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SNV, while the ‘CAAAA’ haplotype comprises all derived
alleles.
The haplotype ‘CAAAA’ is East Asian-speciﬁc. However,
whether this haplotype is speciﬁc to the modern human
remains unknown. To address this question, we examined
putative haplotypes in other vertebrates based on information
in the UCSC Genome Browser or Multiz Alignments of 100
Vertebrates in the UCSC database (Figure 2; Supplementary
Table S2). No other species with the East Asian-speciﬁc
haplotype of modern humans were observed and the common
haplotype was predominantly observed in Haplorhini, and even
archaic humans, including Neanderthal and Denisovan.
Notably, a guanine (ancestral allele) at rs671 in ALDH2
appeared to be consistently conserved in all vertebrates,
including a jawless vertebrate, sea lamprey (Petromyzon mar-
inus). Therefore, the nonsynonymous substitution at this site
might be disadvantageous for survival in vertebrates.
To examine genetic polymorphisms within nonhuman
primates, variant call format data sets of 38 chimpanzees
(Pan troglodytes and Pan paniscus), 31 gorillas (Gorilla gorilla
and Gorilla beringei) and 10 orangutans (Pongo pygmaeus and
Pongo abelii) were retrieved from the Great Ape Genome
Project database.23 We subsequently searched allele frequencies
at the counterparts to ﬁve human hypertension-related SNVs
densely located at 12q24.12–12q24.13. However, the variant
call format data sets did not contain any information for the
allele frequencies, suggesting that the three primates examined
do not have genetic polymorphisms at these sites. Therefore,
it is likely that the East Asian-speciﬁc haplotype identiﬁed in
the present study is human-speciﬁc.
Comparison of clinical parameters between East Asian-
speciﬁc and common haplotypes
In the Inabe cohort, the prevalence of hypertension in subjects
with the East Asian haplotype (case= 1052 and control= 2111)
was signiﬁcantly lower than in subjects with the common
haplotype (case= 4875 and control= 3141; odds ratio= 0.32,
Po2.2 × 10− 16 by Fisher’s exact test). The odds ratio was lower
than that of each SNV (the mean odds ratio was 0.78, see
above), suggesting that the effect of haplotype on hypertension
is greater than that of individual SNVs. In the combined group
of homozygotes with the East Asian haplotype (CAAAA/
CAAAA) and heterozygotes with East Asian and common
haplotypes (CAAAA/TGGGT), the mean SBP and DBP values
were 119.6± 0.32 and 73.6± 0.24, respectively. These values
were signiﬁcantly lower than the mean SBP (121.5± 0.31) and
DBP (75.5± 0.24) values of homozygotes with the common
haplotype (Po1.8× 10− 5 and o1.6 × 10− 8 for SBP and DBP,
respectively, using Welch’s t-test), according to cross-sectional
analysis using clinical parameters of subjects in the latest year
for which data were available. These results suggest that the
East Asian haplotype is protective against hypertension.
To survey the effect of different lifestyle variables (drinking,
smoking and exercise status) on hypertension among diplo-
types, we compared the SBP and DBP values of each diplotype
using cross-sectional analysis data in a pairwise fashionT
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(for example, smokers and non-smokers). The mean SBP and
DBP values of smokers and drinkers were signiﬁcantly higher
than those of non-smokers and non-drinkers among subjects
homozygous for the common diplotypes (Supplementary
Figure S4a–d). Moreover, the comparison of DBP values in
heterozygotes with the common and East Asian haplotypes
showed signiﬁcant differences between groups based on
smoking or drinking status. The differences in the DBP values
of smokers and non-smokers with East Asian haplotypes were
smaller than those in subjects with a common haplotype.
Stratiﬁcation based on smoking status revealed the degree of
difference between the two groups with the ‘CAAAA/CAAAA’
diplotype was 0.35mmHg, and the degree of difference
between the two groups with ‘TGGGT/CAAAA’ and
‘TGGGT/TGGGT’ diplotypes was 3.01 and 4.33mmHg,
respectively (Supplementary Figure S4b). This ﬁnding suggests
that compared with the common haplotype, the East Asian-
speciﬁc haplotype is less susceptible to the adverse effects of
smoking. Using all six detected SNVs in the dominant model,
we also estimated phased haplotypes and repeated the
stratiﬁcation analysis. Similar results were observed in analyses
based on six SNVs (including rs12229654 at 12q24.11;
Supplementary Figure S5a–d).
Identiﬁcation of a novel genetic variant in the COL6A5 gene
For the recessive model, one SNV (rs11917356) in COL6A5
showed signiﬁcant association with SBP in the GEE model with
normal and t reference distributions, and the value of approxdf
was 60.3. We compared the mean SBP and DBP values
between genotypes for the candidate SNV. SBP and DBP
values in subjects with the GG or GA genotype (mean
SBP= 120.9± 0.22 and mean DBP= 74.8± 0.17) were signiﬁ-
cantly higher than those in subjects with the AA genotype
(mean SBP= 117.7± 0.64 and mean DBP= 72.7± 0.48;
P= 2.4 × 10− 6 and 5.1× 10− 5 for mean SBP and mean DBP,
respectively, by Welch’s t-test). This ﬁnding suggests that the
‘A’ allele is protective against hypertension.
On the basis of the information obtained from the 1000
Genomes Project21 and iJGVD22 databases, we examined allele
frequencies of focal SNVs within human populations (Table 3).
Remarkably, the frequency of the derived allele ‘G’ at
rs11917356 was highest in Japan (~70%), and the ‘G’ allele
was major in East Asian populations and minor in non-East
Asian populations, suggesting that the frequencies of the
derived alleles have rapidly increased since the split of East
Asian and South Asian lineages.
DISCUSSION
In the present longitudinal EWAS, the GEE model with normal
and t reference distributions demonstrated that six SNVs
located on chromosome 12 were signiﬁcantly associated with
the clinical parameters of hypertension, while one SNV of
COL6A5 on chromosome 3 was signiﬁcantly related to SBP.
The effective sample size based on approxdf of these SNVs was
430. In a CHAGE multistudy meta-analysis, the GEE model
using t reference distribution with approxdf ⩾ 10 provided
more accurate P-values than standard GEE models.11
Therefore, the reliability of associations between the clinical
parameters of hypertension and the candidate SNVs detected in
the present study was high.
Figure 2 Comparison of ﬁve hypertension-associated single-nucleotide variants (SNVs) among primates. The primate allele identical to the
human ancestral allele is shown in bold. aThe putative allele was estimated based on the UCSC Genome Browser or Multiz Alignments of
100 Vertebrates in the UCSC database. bThe putative allele was estimated based on allele frequencies deposited in the Great Ape Genome
Project database.
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On the basis of the data for the six candidate SNVs on
chromosome 12, we showed that East Asian-speciﬁc alleles (or
haplotype) could be protective against hypertension. Among
the six SNVs, a nonsynonymous nucleotide substitution at
rs671 in ALDH2 altered an amino-acid residue (Table 2).
However, all nucleotide substitutions in the other SNVs were
silent. Therefore, the SNV in ALDH2 may be an important
factor in the onset of hypertension. ALDH2 is a mitochondrial
acetaldehyde dehydrogenase involved in the major pathway of
alcohol metabolism. The rs671 G to A transition in ALDH2
exon 12 changes the amino-acid at position 504 (E504K),
resulting in defective enzyme activity.24,25 Previous studies
reported that the derived ALDH2 allele (A) was predominantly
observed in East Asians, and this allele has potentially expanded
in this area through natural selection in the recent past.26,27
A meta-analysis of GWASs for blood pressure variation in East
Asian populations detected signiﬁcant associations between
rs11066280 of HECTD4 and SBP or DBP values, and an
estimated haplotype comprising eight SNVs showed relatively
high LD (r240.7). Furthermore, haplotypes comprising ﬁve of
the eight SNVs were clearly differentiated into high- and low-
blood-pressure groups.5 In the present longitudinal EWAS,
four of the ﬁve SNVs detected in the previous study (rs3782886
of BRAP, rs671 of ALDH2, and rs2074356 and rs11066280 of
HECTD4) were signiﬁcantly associated with hypertension.
There was high LD among SNVs densely located at 12q24.1,
suggesting that positive selection, acting on the site of rs671 in
ALDH2, alters the allelic frequency of the other ﬁve SNVs
through genetic hitchhiking. Indeed, a signal indicative of a
selective sweep (recent positive selection) was identiﬁed at
12q24.13 near the ALDH2 in two haplotype-based tests.5
Nevertheless, in the present study, the ancestral alleles at the
six detected SNVs appeared to be conserved during the course
of primate evolution. In addition, the protective effect of the
East Asian haplotype on hypertension (the odds ratio= 0.3)
was greater than that of each East Asian allele (the mean odds
ratio= 0.8). Therefore, the effect of genetic factors other than
rs671 remains controversial. It is intriguing to determine how
and why the haplotype generated by unusual alleles at each
SNV has spread in East Asians.
As rs671 of ALDH2 inﬂuences alcohol intake or consump-
tion, the drinking status of subjects is potentially associated
with hypertension. Cross-sectional analysis using the clinical
parameters for subjects in the latest year for which data were
available revealed that the prevalence of hypertension in non-
drinkers with the East Asian allele at rs671 was signiﬁcantly
lower than that in non-drinkers with the common allele
(P= 0.009 by Fisher’s exact test, odds ratio= 0.87). To further
consider the effect of alcohol intake and consumption, we re-
analyzed the relationship between longitudinal changes in the
prevalence of hypertension, SBP, or DBP values and six
detected SNVs in the dominant model using the GEE method
after adjustment for alcohol intake or alcohol consumption
(also including age, gender, body mass index and smoking
status; Supplementary Table S3). The associations of all six
SNVs with clinical parameters of hypertension were supported
by the results of the GEE test, suggesting that the identiﬁed
genetic variants at 12q24.1 could inﬂuence susceptibility to
hypertension.
Given that their genetic variations inﬂuence the incidence of
hypertension, it is unclear how these variants are involved in
the pathogenesis of hypertension. While the immediate cause is
unknown, differences in sodium retention might be associated
with hypertension. Hence, we preliminarily analyzed the
interaction between molecules encoded by genes with the
ﬁve hypertension-associated SNVs and molecules directly or
indirectly related to the regulation of sodium retention (such as
RAC1, ADRB2, WNK4, NR3C2, SLC12A3, SCNN1A and
SCNN1B). To perform this analysis, we used Cytoscape version
3.4.028 software, which automatically integrates human
molecular interaction data from different public databases
(Supplementary Figure S6). The integrated network did
not show any direct interaction among the analyzed
molecules. However, the network displayed some potential
indirect interactions. For example, HECTD4 was associated
with YWHAZ, which is involved in the regulation of
signaling pathways. Meek et al.29 previously showed the
physical association of these molecules. According to the
molecular INTeraction database (http://mint.bio.uniroma2.it),
Pozuelo-Rubio et al.30 reported the association of YWHAZ
and WNK4, a regulator of renal electrolyte transport, using
tandem afﬁnity puriﬁcation. WNK4 has an important role in
blood pressure regulation.31 In addition, in the generated
network, ALDH2 was indirectly associated with the WNK4
via CUL3, a component of ubiquitin E3 ligase, according to
the Biological General Repository for Interaction Data sets
(https://thebiogrid.org/). These results are not direct evidence
that the four hypertension susceptibility genes identiﬁed at
12q24.1 in the present study inﬂuence the sodium retention
ability, and further analyses are required to reveal the
pathogenesis of hypertension.
Comparison of the DBP values between smokers and non-
smokers in each diplotype of phased haplotypes (East Asian
and common haplotypes) showed a clear pattern. The degree
of differences of DBP values between the two groups deﬁned
according to smoking status decreased with the number of East
Asian haplotypes in the diplotype. These data were derived
from the cross-sectional analysis using clinical parameters of
subjects in the latest year for which data were available.
Cigarette smoking potentially increases the risk of cardiovas-
cular diseases.32,33 Nevertheless, in the present study, subjects
with the East Asian haplotype were less susceptible to the
adverse effects of smoking on hypertension compared with
those with the common haplotype. Thus, the interaction
between the genetic factor of common haplotype and the
environmental factor of smoking may intensify the adverse
effects on hypertension.
The longitudinal EWAS for the recessive model showed one
candidate SNV in COL6A5. According to information on
GWAS central (http://www.gwascentral.org/) and GWAS cata-
log (https://www.ebi.ac.uk/gwas/) databases, rs11917356 is a
novel genetic variant associated with hypertension. In addition,
Longitudinal EWAS for hypertension in a Japanese population
Y Yasukochi et al
8
Experimental & Molecular Medicine
the frequency of derived allele ‘G’ was remarkably higher in
East Asia (particularly in Japan) than in the other ethnic
populations. This ﬁnding suggests that the derived allele rapidly
spread throughout East Asia. However, the mean SBP and DBP
values in subjects with the derived allele were signiﬁcantly
higher than those in subjects with the ancestral allele ‘A’. Given
that the ‘G’ allele in Japanese individuals could be susceptible to
hypertension, it remains unclear why the frequency of the allele
has increased in East Asia. It is possible that the derived allele
confers adaptability to environments in East Asia in return for
the risk of hypertension incidence.
COL6A5 (collagen type VI alpha 5 chain) is a member of the
collagen superfamily. A previous study reported that COL6A5
is a susceptibility gene for the chronic inﬂammatory skin
disorder atopic dermatitis.34 The rs11917356 represents a
G4A transition that alters the amino-acid residue at position
982 (D982G), but this substitution is unlikely to have a strong
impact on protein function, according to SIFT (http://sift.jcvi.
org/, score= 0.73) and PolyPhen-2 (http://genetics.bwh.har-
vard.edu/pph2/index.shtml, score= 0.093). The COL6A5 gene
is primarily expressed in the skin but is also expressed in the
lungs, small intestine, colon and testes.34 In addition, COL6A5
protein is strongly expressed around blood vessels at the
interface between the papillary and reticular dermis.35 Thus,
the amino-acid change in COL6A5 may be associated with
hypertension through changes in blood vessel elasticity (or
stiffness). Although the pathogenesis of hypertension resulting
from genetic variation at rs11917356 remains unclear, the
results of the present study suggest that the genetic variant of
COL6A5 confers susceptibility to hypertension.
There were certain limitations in the present study. First, the
longitudinal EWAS was conducted only in a local Japanese
population. Given that the subjects were community-dwelling
individuals who visited the health-care center for an annual
health check-up, the selection bias was small in the present
study. Although multicenter longitudinal EWASs improved the
accuracy and reliability of these results, those data are not
currently available. Therefore, the replication of longitudinal
EWASs in other Japanese populations or other ethnic groups is
required to clarify the associations of the identiﬁed SNVs with
hypertension. Second, the functional relevance of candidate
SNVs identiﬁed in the longitudinal EWAS to the pathogenesis
of hypertension remains unclear. Third, the follow-up period
of annual health check-ups varied from 1 to 11 years among
individuals.
In conclusion, the results of the present study suggest that
the East Asian-speciﬁc haplotype, comprising SNVs genotyped
on 12q24.1 and a COL6A5 ancestral allele of which the
frequency may have recently decreased in East Asians, may
represent protective genes against essential hypertension. In
addition, the East Asian-speciﬁc haplotype may be less suscep-
tible to the adverse effects of smoking on hypertension. Clinical
genotyping for the SNVs detected in this longitudinal EWAS
may be useful for precise and/or personalized medicine.
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